Close



Feb 29, 2024 04:01PM
May 9, 2023 04:01PM
Jan 9, 2023 08:13AM
Jan 9, 2023 08:00AM
Jan 9, 2023 08:00AM
Nov 8, 2022 04:01PM
Nov 8, 2022 04:01PM Xenon Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Nov 3, 2022 08:30AM
Nov 3, 2022 08:30AM
Aug 9, 2022 04:01PM
Aug 9, 2022 04:01PM
Jun 21, 2022 07:01AM
Jun 21, 2022 07:00AM
Jun 21, 2022 07:00AM Xenon Pharmaceuticals Announces Positive Outcome of End-of-Phase 2 Meeting with the FDA
May 10, 2022 04:01PM
May 10, 2022 04:01PM
Apr 12, 2022 06:37AM
Mar 1, 2022 04:01PM
Mar 1, 2022 04:01PM
Jan 19, 2022 06:04PM
Jan 12, 2022 08:04AM Xenon Pharmaceuticals (XENE) Collaboration with Neurocrine (NBIX) Biosciences Achieves $15M Regulatory Milestone
Jan 12, 2022 08:01AM
Jan 12, 2022 08:00AM
Jan 12, 2022 08:00AM
Jan 10, 2022 08:34AM
Jan 10, 2022 08:30AM
Jan 10, 2022 08:30AM
Dec 3, 2021 07:01AM Xenon Pharmaceuticals (XENE) Reports Additional Positive Data from Phase 2b ‘X-TOLE’ Trial
Dec 3, 2021 07:00AM
Dec 3, 2021 07:00AM
Nov 10, 2021 04:01PM
Nov 10, 2021 04:01PM
Oct 4, 2021 07:01AM
Oct 4, 2021 07:00AM
Oct 4, 2021 07:00AM Xenon Pharmaceuticals Announces Positive Topline Results from Phase 2b ‘X-TOLE’ Clinical Trial of XEN1101 for the Treatment of Focal Epilepsy
Sep 8, 2021 08:32AM
Sep 8, 2021 08:30AM
Sep 8, 2021 08:30AM
Aug 11, 2021 04:01PM
Aug 11, 2021 04:01PM
May 11, 2021 04:01PM
May 11, 2021 04:01PM Xenon Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
Mar 8, 2021 04:05PM
Mar 8, 2021 04:05PM
Mar 1, 2021 04:01PM
Mar 1, 2021 04:01PM
Jan 14, 2021 08:08AM
Jan 14, 2021 08:00AM
Jan 14, 2021 08:00AM Xenon Pharmaceuticals Outlines Key Milestone Opportunities and Planned Leadership Transition in 2021
Nov 5, 2020 05:34PM

251,865 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All